Skip to main content
Clinical Trials/NCT03076710
NCT03076710
Withdrawn
Not Applicable

Two-Stage, Pilot, Prospective, Observational Study of Post-Operative Pain Management Following Spine Surgery

University of Miami1 site in 1 countryJuly 31, 2017

Overview

Phase
Not Applicable
Intervention
Opioids delivered through PCA
Conditions
Pain Management
Sponsor
University of Miami
Locations
1
Primary Endpoint
Pain severity at the site of surgery
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

The primary objective of this pilot study is to assess the feasibility of comparing two standardized approaches to manage post-operative pain following spine surgery: one approach using Patient Controlled Analgesia (PCA) devices to deliver opioid analgesics, and the other approach using EXPAREL® infiltration at the site of surgery and nurse-administered opioid analgesics.

Detailed Description

The study will assess the feasibility of the methods proposed, including recruitment, eligibility, standardization of both post-operative pain management approaches, and assessment of clinical, hospital efficiency, medication use, health services use, and economic outcomes.

Registry
clinicaltrials.gov
Start Date
July 31, 2017
End Date
March 2022
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Steven Vanni

Associate Professor

University of Miami

Eligibility Criteria

Inclusion Criteria

  • Age 18-65
  • Ability to speak, read, and write in English or Spanish
  • Primary indication is low back pain, radiculopathy, disc degeneration, disc herniation, foraminal stenosis, or mild 1-level spondylolisthesis or deformity
  • Scheduled to undergo primary, single level, lumbar fusion surgical procedure at the study center in the next 30 days
  • Willing to provide informed consent, participate in study, and comply with study protocol

Exclusion Criteria

  • Body mass index \>35
  • Pregnant or contemplating pregnancy prior to surgery
  • Current or previous psychiatric, behavioral, or emotional disorder that may interfere with postsurgical pain, analgesia, or opioid use according to treating surgeon
  • Prior treatment for alcohol, recreational drug, or opioid abuse
  • Chronic inflammatory conditions (e.g. Crohn's, lupus, rheumatoid arthritis)
  • Chronic neurologic conditions (e.g. multiple sclerosis, Parkinson's)
  • Serious spinal conditions (e.g. cauda equina syndrome, infection, tumor, fracture)
  • Hypersensitivity or allergy to local anesthetics
  • Previous surgery in lumbar spine (i.e. other than microdiscectomy);
  • Continuous (e.g. daily) opioid consumption for more than 30 days prior to surgery

Arms & Interventions

Opioids delivered through PCA

PCA devices used to deliver opioids

Intervention: Opioids delivered through PCA

EXPAREL® infiltration

EXPAREL® infiltration at the site of surgery and nurse-administered opioid as needed

Intervention: EXPAREL® infiltration

Outcomes

Primary Outcomes

Pain severity at the site of surgery

Time Frame: 4 hours post surgery

Numerical Rating Scale 0 (no pain) to 10 (worst pain imaginable).

Study Sites (1)

Loading locations...

Similar Trials